December 6, 2011

A drug made by Pfizer appears to work in treating overactive bladder in elderly patients, according to results of a clinical trial released Monday.

December 6, 2011

Days after its launch of a generic version of Pfizer's cholesterol-lowering drug Lipitor, Ranbaxy Labs has launched a related drug as an authorized generic.

December 5, 2011

As many as 111 million Americans had gotten a flu shot by mid-November, representing 36% of the 305 million Americans over the age of 6 months, the Centers for Disease Control and Prevention stated in a media telebriefing Monday afternoon.

December 5, 2011

Senior Walmart executives regularly invoke the name of Sam Walton when it serves to reinforce a point regarding the company’s business model or the cultural principles on which Walton is said to have founded the company.

December 5, 2011

Following the settlement of a patent-litigation suit with Swiss drug maker Novartis over the patch Vivelle-Dot (estradiol transdermal system), a drug for treating symptoms of menopause, Mylan said it had received a patent license to begin selling its version of the drug in December 2013.


December 2, 2011

A drug for treating immune system disorders is available again following a voluntary market withdrawal last summer.

December 2, 2011

Pfizer completed its acquisition of a drug maker that focuses on the development of skin scarring treatments.

December 1, 2011

Many people with Type 2 diabetes have managed to integrate the treatments they must take into their daily lives, but many do not reach their blood-glucose goals after they start insulin therapy.

December 1, 2011

Pfizer's efforts to protect the sales of its blockbuster cholesterol drug Lipitor have attracted scrutiny from members of Congress, according to published reports.

November 30, 2011

While sales figures for pharmaceuticals are frequently reported on, drugs for people's four-legged friends also are a money maker.

November 30, 2011

Ranbaxy Labs was supposed to launch its generic version of the world's top-selling drug Wednesday, but a competitor beat it to the punch as the former waits for final Food and Drug Administration clearance.

November 29, 2011

A drug designed to prevent stroke and systemic embolism in patients with atrial fibrillation has been accepted for review by the Food and Drug Administration.

November 28, 2011

Bayer HealthCare and Regeneron Pharmaceuticals have started a late-stage clinical trial in China to evaluate a drug for eye disorders, the companies said Monday.

November 28, 2011

A U.S. subsidiary of Takeda Pharmaceutical has filed for regulatory approval of a drug designed to treat Type 2 diabetes, the company said.

November 23, 2011

The Food and Drug Administration has approved the first drug for insomnia in which patients wake in the middle of the night and have trouble returning to sleep.

November 23, 2011

Pfizer is looking to sell its top-selling cholesterol drug directly to consumers at a greatly reduced price after the patent expires, according to published reports.

November 23, 2011

Facebook wars happen all the time, but it's not often that drug manufacturers duke it out online.

November 23, 2011

British drug maker Shire is looking to make a biotech drug for a rare genetic disorder at a new manufacturing plant in Massachusetts.

November 22, 2011

Pfizer will acquire a San Diego-based drug maker focused on treatments for skin scarring, the company said Tuesday.

November 21, 2011

A drug made by Amgen delayed the spread of prostate cancer to the bones in men with the disease and prolonged the survival of men with the condition, according to results of a late-stage clinical trial.

November 21, 2011

After being unanimously recommended for approval by a Food and Drug Administration panel, the FDA has approved an eye disorder treatment created by Regeneron Pharmaceuticals.

November 21, 2011

Drug maker Gilead Sciences will acquire Pharmasset for $11 billion, or $137 per share, Gilead said Monday.

November 21, 2011

Perrigo on Monday named Christopher Roop to the post of VP corporate development.

November 21, 2011

Canadian drug maker Valeant Pharmaceuticals International is acquiring an Australian drug maker for up to A$700 million, Valeant said.